Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Covis Pharmaceuticals
Covis Pharmaceuticals
Activities:
Manufacturing
Cardiovascular
Mental Health
Pharmaceutical
Cognitive
X
LinkedIn
Trending Articles
Driving sustainable transition in pharmaceutical packaging
The pharmaceutical industry, although dedicated to improving human health, is increasingly grappling with the challenge of balancing this mission with environmental...
Blood plasma processing: when every drop counts
Plasma derivatives obtained from human blood support the treatment of various diseases — from haemophilia and antigen defects to COVID-19. The products are in high demand and...
Olon continues its growth with a new acquisition
The acquisition of Huvepharma Italia Srl increases production capacity and expands market presence
AI in IT/OT integration: how technology can overcome cybersecurity hurdles
Manufacturing Chemist (MC) spoke to Rene Hackl (RH), Managing Director at Phytools about how artificial intelligence (AI) can revolutionise IT/OT integration
Have you seen the latest from METTLER TOLEDO on advanced filling solutions?
Join METTLER TOLEDO’s free webinar to explore weight-based filling for greater accuracy and control
Upcoming event
Boston Biotech Week
23-26 September, 2024 | Convention and exhibition | Boston, US
See all
Related Content
Covis Pharma names Chairman of the Board
Rajiv De Silva has been chosen as Chairman of the Board of Director effective immediately
Covis Pharma appoints Dean Mitchell as Executive Chairman
Takes responsibility for leadership of Covis Pharma Holdings and for the overall direction of the company
Finance
Covis Pharma gains rights to certain GSK drugs in US and Puerto Rico
Covis aims to build sales in new and adjacent therapeutic areas
Subscribe now